Parent Encouragement And Coaching of Happiness in Youth
PEACHY
Maternal Positive Affect Socialization and Child Neural Reward Response
2 other identifiers
interventional
180
1 country
1
Brief Summary
The goal of this mechanistic clinical trial is to examine whether parent-coaching aimed at increasing child positive affect will increase child neural response to reward. The main questions it aims to answer are: Aim 1. Characterize child neural reward response and its relation to maternal socialization of positive emotions at baseline in healthy young children. Aim 2. Evaluate how coaching-related changes in maternal socialization of positive emotion expression contribute to increases in child neural reward response over time. Aim 3. Examine how maternal socialization of positive emotion expression contributes to increases in child neural reward response in the moment. Participating mother-child dyads will be randomized to either 3 sessions of parent coaching of child positive affect or 3 sessions of a general parenting support intervention and neural response to reward and affective behavior will be examined pre and post intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Oct 2025
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2024
CompletedFirst Posted
Study publicly available on registry
December 10, 2024
CompletedStudy Start
First participant enrolled
October 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2029
January 28, 2026
January 1, 2026
3.3 years
December 5, 2024
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reward Positivity (RewP)
The Reward Positivity (RewP) ERP component of the EEG signal is the mean amplitude (μV; microvolt) on gain-loss trials during receipt of reward related feedback in a computerized reward task with higher RewP amplitudes indicating greater reward response (i.e., more favorable outcome).
From baseline week 1 to final assessment week 5 (week 10 maximum)
Secondary Outcomes (3)
Parent Responses to Child Positive affect Scale (PRCPS)
From baseline week 1 to final assessment week 5 (week 10 maximum)
Behavioral Coding of Parental Encouragement of Child Positive Emotion
From baseline week 1 to final assessment week 5 (week 10 maximum)
Late Positive Potential (LPP)
From baseline week 1 to final assessment week 5 (week 10 maximum)
Study Arms (2)
Parent Coaching
EXPERIMENTALParents will receive 3 sessions based on PCIT-ED aimed at increasing child positive affect.
Active Control
ACTIVE COMPARATORParents will receive 3 sessions based on traditional PCIT providing more general parenting supporting, including basic psychoeducation and parenting skills.
Interventions
Three sessions of parent coaching of child positive affect will be administered based on modules from PCIT-ED.
General parent support and psychoeducation based on components of standard PCIT.
Eligibility Criteria
You may qualify if:
- Birth mother (biologically female, any gender)
- Providing regular care for participating child (i.e., at least 50% of time)
- Elevated, clinically significant levels of depression (16 or higher on CES-D)
- Aged 18+
You may not qualify if:
- Lifetime history of a bipolar disorder
- Lifetime history of a psychotic disorder
- Aged 4-6 years
- T-score greater than 63 on the internalizing or externalizing composites of the CBCL
- Lifetime history of a psychiatric illness
- Lifetime history of neurodevelopmental disorder
- Lifetime history of neurological disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Judith M Morgan, PhD
University of Pittsburgh
- PRINCIPAL INVESTIGATOR
Lauren M. Bylsma, PhD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 5, 2024
First Posted
December 10, 2024
Study Start
October 28, 2025
Primary Completion (Estimated)
February 1, 2029
Study Completion (Estimated)
February 1, 2029
Last Updated
January 28, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- We will begin to upload data to the NIH NDA beginning in July 2025 per NIMH requirements, which would then be made publicly available by November 2025. Data in the NDA will be made available indefinitely as long as the NDA exists as a resource.
- Access Criteria
- Informed consent documents, protocol information, and statistical analysis plan information will all be uploaded to clinicaltrials.gov. Access to participant level data will be managed by the NIH National Data Archive where all the individual participant data and supporting information will be uploaded. Additional data regarding statistical analyses and corresponding code will be provided as supplemental material to publications that use this data. Since this is a mechanistic clinical trial and not an RCT, a CSR is not applicable.
Data will be shared with the NIH NDA per NIH requirements, which include all primary study measures and demographic information. Participant identifying information is used to create an anonymized GUID to identify participants in the NDA but no identifiable information will be shared publicly.